[PDF] Top 20 Dinámica y Competitividad de las Exportaciones Tecnológicas Colombianas
Has 8213 "Dinámica y Competitividad de las Exportaciones Tecnológicas Colombianas" found on our website. Below are the top 20 most common "Dinámica y Competitividad de las Exportaciones Tecnológicas Colombianas".
Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: the Path to Least Resistance
... of mutant FLT3 receptor ...both FLT3-ITD and FLT3-D835Y mutant cell lines with an IC50 of less than 10nM ...of FLT3-ITD-TKD mutant lines, although TKD1 mutations may ... See full document
5
Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: the Path to Least Resistance
... Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase ... See full document
6
Chronic FLT3 ITD signaling in acute myeloid leukemia is connected to a specific chromatin signature
... a signaling molecule regulating growth (class I mutation) (Renne- ville et ...with signaling having wide-ranging impacts on gene ...chronic signaling by a mutated FLT3 growth factor receptor ... See full document
65
Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
... early myeloid and lymphoid progenitor cells also express FLT3, we detected the FLT3 expression on CD34 + HSPCs, which showed no significant difference compared with five leukemia cell lines ... See full document
7
Targeting CDK1 promotes FLT3 activated acute myeloid leukemia differentiation through C/EBPα
... of leukemia by multiple mechanisms, such as transcription- al and translational silencing, as well as genetic mutations and posttranslational modifications, which render C/EBPα protein ...nonphosphorylatable ... See full document
105
Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature
... a signaling molecule regulating growth (class I mutation) (Renne- ville et ...with signaling having wide-ranging impacts on gene ...chronic signaling by a mutated FLT3 growth factor receptor ... See full document
35
Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors
... as oncogenic drivers in both mouse models of leukemia and human AML cells [8, 9], and therefore represent important therapeutic ...(TKIs) targeting FLT3 have been investigated in clinical ... See full document
97
CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia
... of FLT3-ITD mutation, improving the knowledge of this AML subgroup pathophysiology appears as an essential task for the next ...Major signaling pathways activated by FLT3- ITD have been identified, ... See full document
62
Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress
... in acute myeloid leukemia (AML), and is associated with short disease- free survival following ...by FLT3-ITD that also promotes its signaling in a positive feedback ...in ... See full document
113
Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications
... that FLT3 inhibitors may have only a limited role as single-agent therapies, at least in patients with refractory or repeatedly relapsing ...with FLT3-ITD muta- tions can respond if adequate drug ... See full document
8
FLT3 inhibitors: clinical potential in acute myeloid leukemia
... pertinent FLT3 TKI, as accumulated evidences pinpointed that AML cells may be addicted to FLT3-ITD-dependent ...different resistance mechanisms that encompass FLT3 TKD amino acid ... See full document
98
The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia
... Immunoblot analysis of downstream signaling pathways. Three million exponentially growing cells were cultured in cRPMI supplemented with vehicle, control TKI, or the indicated concentration of kinase inhib- itor ... See full document
5
Molecular targeting in acute myeloid leukemia
... Acute myeloid leukemia (AML) is a heterogenous disease associated with distinct genetic and molecular abnormali- ...intracellular signaling pathways, epigenetics, and apoptosis of the ... See full document
7
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
... drug resistance was provided by Zahreddine et ...drug resistance with elevated levels of GLI1 and the UDP glucuronosyltransferase (UGT1A), which can inactivate ribavirin by glucuronidation, thus prevent- ... See full document
265
Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy
... of FLT3 mutations in only a subset of AML cells suggests that they may be disease promoting as opposed to ...aberrant signaling independent of mutant FLT3-mediated signaling may ... See full document
9
Targeting the mitochondria in acute myeloid leukemia
... (BCL-2, BCL-W, BCL-XL, A1, and MCL-1). They are located on the outer mitochondrial membrane (Fig. 2) and interact with other members of this family known as “effectors” (BAK, BAX, and BOK) through their BH3 domain. These ... See full document
6
FLT3 Mutations: Significance in Paediatric AML
... Quizartinib was shown to be considerably more potent than other TKI inhibitors [38,39]. In 2012, a phase 2 trial was conducted with Quizartinib in relapsed or refractory FLT3/ITD AML patients [40,41]. This drug ... See full document
7
Original Article Double CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITD
... of acute myeloid leukemia (AML) is the differentiation arrest and neoplastic accumulation of myeloid precursor cells in the bone ...of myeloid cell proliferation, differentia- tion, and ... See full document
16
Schranz, Katrin (2019): Investigation of AML-specific FLT3 mutations – from next generation diagnostics to combined targeted therapy. Dissertation, LMU München: Fakultät für Biologie
... Moreover, targeting FLT3 seems to be attractive for minimal residual disease eradication during consolidation or maintenance therapy to minimize relapse rates and to prolong EFS and ...target FLT3, ... See full document
11
PIM 1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia
... Results: We observed that expression of PIM-1 mRNA was higher in AML patients than in healthy individuals and in complete remission AML patients (P = 0.0177). Further, high PIM-1 mRNA levels were more associated with ... See full document
8
Related subjects